Pharmaceuticals

Drug Development Drug Pricing Drug Approval Drug Safety Clinical Trials Weight Loss Drugs Biotechnology Prescription Drugs Drug Regulation Drug Manufacturing

4 ARTICLES

23h ago

FDA Approves Sunharbo, First Factor XIa Anticoagulant, to Prevent Repeat Strokes

Late‑stage trials found the drug reduced recurrent non‑cardioembolic ischemic strokes without raising overall major bleeding risk, shifting questions to coverage and real‑world use.

4 ARTICLES

23h ago

Stopping GLP‑1 Drugs Linked to Higher Rates of Heart Attack, Stroke and Death

Stories older than 24h

4 ARTICLES

yesterday

MAR001 Cuts Triglycerides Dramatically in Phase 2b Trial

7 ARTICLES

yesterday

Lilly’s Foundayo Pill Significantly Improves Sleep Apnea in Late‑Stage Trials

4 ARTICLES

yesterday

Tenax Hit With Securities Class Action After Phase 3 Failure and Nearly 90% Share Plunge

4 ARTICLES

3d ago

Small Study Suggests Pill Could Put Hormone‑Driven High Blood Pressure Into Long‑Term Remission

6 ARTICLES

4d ago

Moderna Posts Profit and Raises 2026 Revenue Outlook as New mRNA Products Gain Traction

5 ARTICLES

4d ago

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

4 ARTICLES

5d ago

AstraZeneca Reportedly Offers About $10 Billion for Rhythm Pharmaceuticals

3 ARTICLES

5d ago

UK State Fund Backs Startup Using GPU Quantum Chemistry to Train Drug‑Discovery AI

11 ARTICLES

6d ago

FDA Tentatively Approves Generic Lenacapavir for 120 Low‑ and Middle‑Income Countries

4 ARTICLES

6d ago

DEA Take Back Day Removes More Than 645,000 Pounds of Unused Medications Nationwide

5 ARTICLES

last wk.

Pfizer Beats Q3 Estimates and Raises 2026 Outlook

8 ARTICLES

last wk.

Macleods Recalls 3,744 Bottles of Blood Pressure Combo After Dissolution Failure

3 ARTICLES

last wk.

Tumor Loss of TNKS1 Creates a Drug Window to Block the WNT Cancer Driver

4 ARTICLES

last wk.

FDA Accepts uniQure’s Huntington’s Gene Therapy for Priority Review, Sets May 1, 2027 Decision Date

3 ARTICLES

last wk.

AstraZeneca Launches $2bn Reshaping to Fund Drug Pipeline

Pharmaceuticals

FDA Approves Sunharbo, First Factor XIa Anticoagulant, to Prevent Repeat Strokes

Stopping GLP‑1 Drugs Linked to Higher Rates of Heart Attack, Stroke and Death

MAR001 Cuts Triglycerides Dramatically in Phase 2b Trial

Lilly’s Foundayo Pill Significantly Improves Sleep Apnea in Late‑Stage Trials

Tenax Hit With Securities Class Action After Phase 3 Failure and Nearly 90% Share Plunge

Small Study Suggests Pill Could Put Hormone‑Driven High Blood Pressure Into Long‑Term Remission

Moderna Posts Profit and Raises 2026 Revenue Outlook as New mRNA Products Gain Traction

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

AstraZeneca Reportedly Offers About $10 Billion for Rhythm Pharmaceuticals

UK State Fund Backs Startup Using GPU Quantum Chemistry to Train Drug‑Discovery AI

Never miss stories about

Pharmaceuticals

FDA Tentatively Approves Generic Lenacapavir for 120 Low‑ and Middle‑Income Countries

DEA Take Back Day Removes More Than 645,000 Pounds of Unused Medications Nationwide

Pfizer Beats Q3 Estimates and Raises 2026 Outlook

Macleods Recalls 3,744 Bottles of Blood Pressure Combo After Dissolution Failure

Tumor Loss of TNKS1 Creates a Drug Window to Block the WNT Cancer Driver

FDA Accepts uniQure’s Huntington’s Gene Therapy for Priority Review, Sets May 1, 2027 Decision Date

Fresenius Secures Exclusive Options on 37 WuXi Biosimilar Candidates

FDA Grants Accelerated Approval to Voceryq, First Plasmid DNA Immunotherapy

AbbVie Raises Full‑Year Profit Forecast After Third‑Quarter Beat

AstraZeneca Launches $2bn Reshaping to Fund Drug Pipeline

Never miss stories about

Pharmaceuticals